EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency

Kristina Allen-Brady, Barry Moore, Lauren E Verrilli, Margaret A Alvord, Marina Kern, Nicola Camp, Kristen Kelley, Joseph Letourneau, Lisa Cannon-Albright, Mark Yandell, Erica B Johnstone, Corrine K Welt iD

The Journal of Clinical Endocrinology & Metabolism · 22.04.2025 · 110 (5) · e1678-e1686

DOI: 10.1210/clinem/dgae480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 12.07.2024. Verfasst von Kristina Allen-Brady und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Breast Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NCI NIH HHS, University of Utah and Huntsman Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

DNA damage/repair gene variants are associated with both primary ovarian insufficiency (POI) and cancer risk.

Objective

We hypothesized that a subset of women with POI and family members would have increased risk for cancer.

Design

Case-control population-based study using records from 1995 to 2022.

Setting

Two major Utah academic health care systems serving 85% of the state. Subjects Women with POI (n = 613) were identified using International Classification of Diseases codes and reviewed for accuracy. Relatives were linked using the Utah Population Database.

Intervention

Cancer diagnoses were identified using the Utah Cancer Registry. Main Outcome Measures The relative risk of cancer in women with POI and relatives was estimated by comparison to population rates. Whole genome sequencing was performed on a subset of women.

Results

Breast cancer was increased in women with POI (OR, 2.20; 95% CI, 1.30-3.47; P = .0023) and there was a nominally significant increase in ovarian cancer. Probands with POI were 36.5 ± 4.3 years and 59.5 ± 12.7 years when diagnosed with POI and cancer, respectively. Causal and candidate gene variants for cancer and POI were identified. Among second-degree relatives of these women, there was an increased risk of breast (OR, 1.28; 95% CI, 1.08-1.52; P = .0078) and colon cancer (OR, 1.50; 95% CI, 1.14-1.94; P = .0036). Prostate cancer was increased in first- (OR, 1.64; 95% CI, 1.18-2.23; P = .0026), second- (OR, 1.54; 95% CI, 1.32-1.79; P < .001), and third-degree relatives (OR, 1.33; 95% CI, 1.20-1.48; P < .001).

Conclusion

Data suggest common genetic risk for POI and reproductive cancers. Tools are needed to predict cancer risk in women with POI and potentially to counsel about risks of hormone replacement therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyBreast NeoplasmsHumansFemaleCase-Control StudiesMiddle AgedAdultUtahRegistriesOvarian NeoplasmsRisk FactorsGenetic Predisposition to DiseaseAged

Stichwörter der Autor:innen

geneticsmenopauseovarian cancerprostate cancer

Autor:innen und Institutionen

  • Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84108, USA.
  • Utah Center for Genetic Discovery, Department of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
  • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
  • Intermountain Healthcare, Murray, UT 84107, USA.
  • Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
  • Huntsman Cancer Institute and Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.

ORCID-Profile: Corrine K Welt

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS
  • University of Utah and Huntsman Cancer Foundation
  • NICHD NIH HHS
  • Utah Population Database
  • National Cancer Institute's SEER Program
  • US Centers for Disease Control and Prevention's National Program of Cancer Registries

Zitieren

APA

Allen-Brady, K., Moore, B., Verrilli, L. E., Alvord, M. A., Kern, M., Camp, N., Kelley, K., Letourneau, J., Cannon-Albright, L., Yandell, M., Johnstone, E. B., & Welt, C. K. (2025). Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency. The Journal of Clinical Endocrinology & Metabolism, 110(5), e1678-e1686. https://doi.org/10.1210/clinem/dgae480

Vancouver

Allen-Brady K, Moore B, Verrilli LE, Alvord MA, Kern M, Camp N, et al. Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency. The Journal of Clinical Endocrinology & Metabolism. 2025;110(5):e1678-e1686. doi:10.1210/clinem/dgae480

BibTeX
@article{AllenBrady2025,
  author = {Allen-Brady, Kristina and Moore, Barry and Verrilli, Lauren E and Alvord, Margaret A and Kern, Marina and Camp, Nicola and Kelley, Kristen and Letourneau, Joseph and Cannon-Albright, Lisa and Yandell, Mark and Johnstone, Erica B and Welt, Corrine K},
  title = {Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {5},
  pages = {e1678--e1686},
  doi = {10.1210/clinem/dgae480}
}
Kostenlos starten →